investor relations

stock information

corporate profile

Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, non-small cell lung cancer, malignant pleural mesothelioma and pleural mesothelioma. Novocure has several additional ongoing or completed clinical trials exploring the use of Tumor Treating Fields therapy in the treatment of glioblastoma, non-small cell lung cancer and pancreatic cancer.

corporate presentationclinical evidence

4

FDA-APPROVED INDICATIONS

35,000+

PATIENTS TREATED THROUGH JANUARY 2025

$605M

ANNUAL NET REVENUES (2024)

$210M

ANNUAL R&D INVESTMENTS (2024)

5

ONGOING PHASE 2 AND PHASE 3 TRIALS

press releases

latest quarterly reports

Q4 2024

latest filings

view all
Loading...

reports

See our online annual reports and more.

view all

2023

annual materials

download proxy statement
download 10-K
download corporate responsibility report
view corporate responsibility report

corporate governance

mission, vision and values

mission
Together with our patients, we strive to extend survival in some of the most aggressive forms of cancer by developing and commercializing our innovative therapy.
vision
Patient-forward: aspiring to make a difference in cancer
Learn more
Values
Innovation
Focus
Drive
Courage
Trust
Empathy

contact us

sign up for email alerts

To receive notifications via email, enter your email address and select at least one subscription below. After submitting your information, you will receive an email. You must click the link in the email to activate your subscription. You can sign up for additional subscriptions at any time.

Novocure Websites

On this site, videos and images identified as Optune users, caregivers or healthcare professionals depict actual patients, caregivers and healthcare professionals. Patient images reflect the health status of the patients at the time each photo or video was taken.

 

 

 

 



Quick links

about us
our therapy
our pipeline
investors relations
careers
news and media
patient-forward

© 2025 Novocure GmbH all rights reserved

GLB-CC-00282 v1.0 March 2025